VERENIUM CORPORATION | 1,678 Euro | -0,005 -0,30 % | |
| WKN: A0X9PR ISIN: US92340P2092 Ticker-Symbol: DVG1 | Stuttgart | 19.06.13 | 08:00 Uhr |
Branche BiotechnologieAktienmarkt Sonstige |
|
|
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 10.06. | Verenium Announces Appointment Of Brian Carter As Vice President Of Grain Processing | 13 | PR Newswire | |
| SAN DIEGO, June 10, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes... Mehr lesen zu: Verenium Announces Appointment Of Brian Carter As Vice President Of Grain Processing | ||||
| 10.06. | Verenium To Sponsor And Present At The 2013 Bio World Congress On Industrial Biotechnology | 14 | PR Newswire | |
| SAN DIEGO, June 10, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes... Mehr lesen zu: Verenium To Sponsor And Present At The 2013 Bio World Congress On Industrial Biotechnology | ||||
| 28.05. | Verenium To Introduce New Enzyme Product At 2013 International Fuel Ethanol Workshop & Expo | 18 | PR Newswire | |
| SAN DIEGO, May 28, 2013 /PRNewswire/ --Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes... Mehr lesen zu: Verenium To Introduce New Enzyme Product At 2013 International Fuel Ethanol Workshop & Expo | ||||
| 23.05. | Verenium To Present At Two Upcoming Conferences | 13 | PR Newswire | |
| SAN DIEGO, May 23, 2013 /PRNewswire/ --Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes... Mehr lesen zu: Verenium To Present At Two Upcoming Conferences | ||||
| 10.05. | Verenium's CEO Discusses Q1 2013 Results - Earnings Call Transcript | 8 | Seeking Alpha | |
| 09.05. | VERENIUM CORP - 8-K, Current Report | - | SEC Filings | |
| 09.05. | Verenium Reports Financial Results For The First Quarter Ended March 31, 2013 | 58 | PR Newswire | |
| SAN DIEGO, May 9, 2013 /PRNewswire/ --Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes,... Mehr lesen zu: Verenium Reports Financial Results For The First Quarter Ended March 31, 2013 | ||||
| 02.05. | Verenium Corporation to Announce First Quarter 2013 Financial Results | 17 | PR Newswire | |
| SAN DIEGO, May 2, 2013 /PRNewswire/ --Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance... Mehr lesen zu: Verenium Corporation to Announce First Quarter 2013 Financial Results | ||||
| 28.03. | Verenium's CEO Discusses Q4 2012 Results - Earnings Call Transcript | 5 | Seeking Alpha | |
| 27.03. | Verenium Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2012 | 37 | PR Newswire | |
| SAN DIEGO, Calif., March 27, 2013 /PRNewswire/ --Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance... Mehr lesen zu: Verenium Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2012 | ||||
| 18.03. | Verenium Corporation To Announce Fourth Quarter And Year End 2012 Financial Results | 29 | PR Newswire | |
| SAN DIEGO, March 18, 2013 /PRNewswire/ --Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes... Mehr lesen zu: Verenium Corporation To Announce Fourth Quarter And Year End 2012 Financial Results | ||||
| 14.03. | Verenium Announces Preliminary Financial Results For Fiscal 2012 | 44 | PR Newswire | |
| SAN DIEGO, March 14, 2013 /PRNewswire/ -- Verenium Corporation (the "Company") (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance... Mehr lesen zu: Verenium Announces Preliminary Financial Results For Fiscal 2012 | ||||
| 12.03. | Verenium To Present At The 25Th Annual Roth Conference | 26 | PR Newswire | |
| SAN DIEGO, March 12, 2013 /PRNewswire/ --Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes... Mehr lesen zu: Verenium To Present At The 25Th Annual Roth Conference | ||||
| 26.02. | Verenium Appoints Holger Liepmann To Its Board Of Directors | 37 | PR Newswire | |
| SAN DIEGO, Feb. 26, 2013 /PRNewswire/ --Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes... Mehr lesen zu: Verenium Appoints Holger Liepmann To Its Board Of Directors | ||||
| 04.02. | Verenium To Sponsor The Renewable Fuels Association 18th Annual National Ethanol Conference | 25 | PR Newswire | |
| SAN DIEGO, Feb. 4, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes... Mehr lesen zu: Verenium To Sponsor The Renewable Fuels Association 18th Annual National Ethanol Conference | ||||
| 04.02. | Verenium Announces Commercial Launch Of Pyrolase HT Product | 31 | PR Newswire | |
| SAN DIEGO, Feb. 4, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes... Mehr lesen zu: Verenium Announces Commercial Launch Of Pyrolase HT Product | ||||
| 30.01. | Novus International And Verenium Announce Important Progress In The Development Of Novel Enzymes For Animal Health & Nutrition | 44 | PR Newswire | |
| ST. LOUIS and SAN DIEGO, Jan. 30, 2013 /PRNewswire/ --Novus International Inc., a leading manufacturer of animal nutrition and health products and Verenium Corporation (Nasdaq: VRNM), a leading industrial... Mehr lesen zu: Novus International And Verenium Announce Important Progress In The Development Of Novel Enzymes For Animal Health & Nutrition | ||||
| 10.12. | Verenium Announces $22.5 Million, Five-Year Secured Financing | 85 | PR Newswire | |
| SAN DIEGO, Dec. 10, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes... Mehr lesen zu: Verenium Announces $22.5 Million, Five-Year Secured Financing | ||||
| 08.11. | Verenium Reports Financial Results For The Third Quarter And Nine Months Ended September 30, 2012 | 34 | PR Newswire | |
| SAN DIEGO, Nov. 8, 2012 /PRNewswire/ --Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance... Mehr lesen zu: Verenium Reports Financial Results For The Third Quarter And Nine Months Ended September 30, 2012 | ||||
| 01.11. | Verenium Corporation To Announce Third Quarter 2012 Financial Results | 20 | PR Newswire | |
| SAN DIEGO, Nov. 1, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes... Mehr lesen zu: Verenium Corporation To Announce Third Quarter 2012 Financial Results | ||||
Seite: 1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| EVOTEC | 2,762 | -0,29 % | Termine 12.6., u.a. Conergy, Evotec, Fraport, Intershop |
| QIAGEN | 14,69 | -0,07 % | QIAGEN-Aktie kommt wieder auf die Beine! |
| BB BIOTECH | 91,61 | +0,38 % | BB Biotech AG: Veröffentlichung gem. § 26 Abs.1 WpHG mit dem Ziel der europaweiten Verbreitung |
| MOLOGEN | 13,99 | 0 % | DGAP-HV: Mologen AG: Bekanntmachung der -13- |
| WILEX | 1,36 | -0,37 % | DGAP-Stimmrechte: WILEX AG (deutsch) |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von